PPRC1 is a prognostic biomarker and key regulator of mitochondrial oxidative phosphorylation in multiple myeloma
PPRC1 acts as a prognostic biomarker and metabolic regulator in MM by sustaining mitochondrial oxidative phosphorylation. These findings highlight PPRC1 as a potential therapeutic target in MM.
Authors
- Xuemei Shu
- Siqi Yan (ORCID: https://orcid.org/0000-0002-5905-3006)
- Tao Guo (ORCID: https://orcid.org/0000-0002-7340-3762)
- Jiayu Wang (ORCID: https://orcid.org/0000-0003-3850-4178)
- Dawei Wang (ORCID: https://orcid.org/0000-0001-7547-0689)
- Qian Xu (ORCID: https://orcid.org/0000-0002-3841-0174)
- Y. Liu (ORCID: https://orcid.org/0000-0001-8908-6194)
- Min Zhang
Institutions
- Ruijin Hospital (CN)
- Shanghai Institute of Hematology (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1080/07853890.2026.2639658
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00